From Medscape Education Cardiology

Reversing DOACs Today for Better Outcomes Tomorrow: A Series of Expert Exchanges

About This Series

With over 6 million patients in the United States receiving an oral anticoagulant (with the majority being direct oral anticoagulants [DOACs]) for thromboprophylaxis, clinicians must be aware of how to recognize and treat DOAC-related bleeds in a timely manner.

In this series of 15-minute accredited programs, clinicians will gain more knowledge on racial/ethnic disparities related to treatment with DOACs, the burden of DOAC-related bleeding and its impact on patient outcomes. Expert faculty will discuss the latest data and guidelines on the use of specific reversal agents for DOAC-related urgent bleeding, and strategies to optimize patient outcomes.  

CME Activities

DOAC Reversal Agents: One Size Does Not Fit All CME / ABIM MOC

Wondering which reversal agent to use? Experts discuss key differences between reversal agents for direct-acting oral anticoagulant (DOAC)-related urgent bleeds.

Available As: Download Slides Transcript
0.25_{ABIM MOC}0.25_CME
Expert Perspectives on Reversal of Oral Anticoagulant Therapy in Patients With GI Bleeding CME / ABIM MOC

Gastrointestinal bleeds are a common occurrence, but what if the patient is anticoagulated? Do you know when anticoagulant reversal should be considered?

Available As: Download Slides Transcript
0.25_{ABIM MOC}0.25_CME
Health Disparities in Diagnosis and Treatment of Patients With Thrombotic Conditions CME / ABIM MOC

Did you know that women have a higher incidence of blood clots than men? Experts discuss health disparities among different groups of people.
Available As: Download Slides Transcript
0.25_{ABIM MOC}0.25_CME
Addressing Trauma Team Challenges in Bleeding Management and Reversal: Your Questions Answered CME / ABIM MOC

A trauma patient presents with major bleeding and you suspect they are anticoagulated -- what do you do next?
Available As: Download Slides Transcript
0.25_{ABIM MOC}0.25_CME